Pfizer Canada (PFE) and BioNTech ( BNTX) announced that Health Canada has authorized Comirnaty Original and Omicron BA.4/BA.5 booster dose for children five through less than 12 years of age. This booster is approved for use at least six months after completing the primary course of the companies’ original COVID-19 vaccine.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PFE:
- Pfizer raises quarterly cash dividend to 41c from 40c per share
- Pfizer, BioNTech get FDA FTD for mRNA-based combination vaccine candidate
- Pfizer, BioNTech announce EUA for bivalent COVID vaccine for children under 5
- Two “Perfect 10” Healthcare Stocks to Beat the Market
- #SocialStocks: EU rules against Meta, despite attempts to settle